Dr. Shantanu Gaur is the Founder and CEO of Allurion, a company pioneering metabolically healthy weight loss solutions. Dr. Gaur is an inventor on over 40 patents and has authored multiple peer-reviewed articles in the obesity space. He graduated summa cum laude from Harvard College and with an M.D. from Harvard Medical School, where he founded Allurion.
The weight loss market is at yet another inflection point. The euphoria of the past three years is now confronting the realities of how obesity medications will scale to address an epidemic that impacts over 1 billion people globally.
In 2024, the weight loss market finds itself at a crossroads, grappling with pivotal questions that will shape the future. The winners will prioritize affordable lifelong care, scalable coaching and support, and a diverse set of solutions that give people second and third chances along their weight loss journeys.
How to turn analytics into actual policy outcomes.
These balloons help people eat less and feel full faster and most importantly, do not involve going under the knife. The birth of the stomach balloon industry is no accident, and it is emblematic of trends that are taking hold of healthcare systems around the world.
To get closer to the dream of personalized obesity treatments, we need more data to piece together which combinations of solutions work for which types of people.
The obesity market needs many solutions that are effective, above all safe, and affordable — then consumers will decide what works best for them, or not.